Teladoc Health uses Visual Website Optimizer (VWO) to run A/B tests on its website, which temporarily hides page content while testing different versions — and in doing so, collects visitor behavior data to optimize the site.
Visitors to Teladoc Health's website may be unknowingly enrolled in A/B tests managed by VWO, a third-party platform that collects behavioral data to compare different page designs — including on pages related to specific health conditions.
Cross-platform context
See how other platforms handle Visual Website Optimizer (VWO) A/B Testing Script and similar clauses.
Compare across platforms →VWO collects visitor interaction data to test different versions of web pages, meaning your browsing behavior on Teladoc's site is analyzed by a third-party optimization platform — including potentially on health condition-specific pages — without explicit disclosure in this document.
1. REGULATORY FRAMEWORK: VWO's behavioral data collection implicates GDPR Art. 6(1)(a) (consent) and Art. 5(1)(b) (purpose limitation), CCPA/CPRA §1798.100, and ePrivacy Directive Art. 5(3) for EU users. VWO sets persistent cookies for visitor segmentation and experiment tracking. HHS OCR's tracking technology guidance applies to any third-party script on a HIPAA-covered entity's site that may receive PHI. 2.
Compliance intelligence locked
Regulatory citations, enforcement risk, and due diligence action items.
Watcher: regulatory citations. Professional: full compliance memo.